We’ve had some very encouraging feedback on our first batch of life science & technology patent highlights, published on January 3rd. Thank you! Please link to our blog and recommend it. The next issue, covering international patent applications published in January, will go online on February 1.
We have been asked – indirectly at least – what interest H.M. Pharma Consultancy, a for-profit organization, might have in offering this free service. Well, depending on what angle you take there are of course several answers to that. But what about this one: the monthly patent highlights are a showcase version of what we are working with as part of our business. Writing this review therefore is not as much work as it may seem at first sight (material aggregates throughout each month), and the company might gain in profile and reputation in return for an incremental investment. That would be pretty close to the mark. True, we could write pages and pages of actual deep analysis for each of the documents in our patent highlights… But sorry, that would then mean hours and hours of actual work – real work, not the fun which it is in the highlight form – and yes, we would have to agree on a fair price. For the average life science patent, there are hundreds of references to follow up on if you research it seriously.
However, on the level you are seeing here the service will always be free and it will (we hope) raise awareness of the fact that patent documents can be an excellent strategic and scientific information source. That’s why we are posting these highlights on a public blog.
By the way, for those who prefer accessing this blog with a feed reader or news aggegator, you can click on the feedreader symbol on top on the sidebar on the left and subscribe. You can also go to http://hmpharmacon.blogspot.com/feeds/posts/default?alt=rss and subscribe to a full RSS feed with the reader of your choice, or decide for dynamic bookmarks.